Work

Nonclinical safety testing of biopharmaceuticals – Addressing current challenges of these novel and emerging therapies

Year: 2015

Type: article

Source: Regulatory Toxicology and Pharmacology

DOI: 10.1016/j.yrtph.2015.07.019

Authors: Frank R. Brennan, Andreas Baumann, Guenter Blaich, Lolke de Haan, Rajni Fagg, Andrea Kiessling, Sven Kronenberg, Mathias Locher, Mark Milton, Jay Tibbitts, Peter Ulrich, Lucinda Weir

Institutions: UCB Pharma (United Kingdom), AbbVie (Germany), GlaxoSmithKline (United Kingdom), Novartis (Switzerland), F. Hoffmann-La Roche AG

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1609976604

FWCI: 1.307

Cites: 32

Cited by: 21

Related to: 10